You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 30, 2026

Drugs Containing Excipient (Inactive Ingredient) MYRISTYL ALCOHOL


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing MYRISTYL ALCOHOL excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing MYRISTYL ALCOHOL excipient

Market Dynamics and Financial Trajectory for Myristyl Alcohol (Pharmaceutical Excipient)

Last updated: January 22, 2026

Executive Summary

Myristyl alcohol, a fatty alcohol derived from myristic acid, functions as a surfactant, emulsifier, and stabilizer within pharmaceutical formulations. The compound's growing inclusion in drug delivery systems, topical products, and as an excipient in nutritional and cosmetic products are shaping the market landscape. This report provides a comprehensive analysis of market dynamics and future financial trajectories, highlighting key drivers, restraints, competitive landscape, and growth forecasts for Myristyl alcohol in pharmaceutical applications.


1. Introduction to Myristyl Alcohol in the Pharmaceutical Sector

Definition & Properties:
Myristyl alcohol, chemically known as tetradecan-1-ol, possesses a molecular weight of 210.4 g/mol and exhibits a waxy, white solid at room temperature. It is recognized for its emulsifying, stabilizing, and surfactant properties, making it a versatile excipient.

Regulatory Status:
Regstered in pharmacopeias such as USP/NF, Myristyl alcohol is generally regarded as safe (GRAS) when used within prescribed limits, supporting its integration into pharmaceutical formulations globally.


2. Market Drivers

2.1. Growing Demand for Advanced Drug Delivery Systems
The shift toward targeted and controlled-release formulations increases reliance on excipients like Myristyl alcohol for emulsion stabilization and controlled drug release [1].

2.2. Expansion in Topical and Cosmeceutical Markets
The rising demand for anti-aging, moisturizers, and skin-care products leverage Myristyl alcohol's emollient and stabilizer functionalities [2].

2.3. Regulatory & Safety Approvals
Global regulatory acceptance facilitates market penetration, with agencies approving Myristyl alcohol for pharmaceutical and cosmetic use, encouraging manufacturers to incorporate it.

2.4. R&D Innovation in Excipients
Ongoing research enhances the utility of fatty alcohols, leading to novel proprietary formulations involving Myristyl alcohol [3].


3. Market Restraints

3.1. Price Volatility of Raw Materials
Fluctuations in feedstock prices for fatty acids underpinning Myristyl alcohol production can impact manufacturing costs [4].

3.2. Competition from Alternative Excipients
Emerging synthetic and bio-based emulsifiers challenge the prominence of Myristyl alcohol.

3.3. Environmental & Sustainability Concerns
Growing emphasis on eco-friendly and sustainable excipient sourcing may restrict reliance on traditional petrochemical-based Myristyl alcohol unless biogenic sources are developed.


4. Market Size & Forecast

Year Global Myristyl Alcohol Market (USD million) CAGR (2023-2030) Key Notes
2022 150 N/A Baseline year for analysis
2023 165 6.7% Post-pandemic growth pickup
2025 210 8.2% Expansion in pharmaceuticals & cosmetics
2027 270 8.5% Integration into advanced drug delivery
2030 350 9.0% Market maturity and innovation

Assumptions:

  • Driven by CAGR in pharmaceutical excipient segment (~8%), as per recent reports [5].
  • Increased regulatory acceptance and R&D activity support growth projections.

5. Regional Market Analysis

5.1. North America

Dominant due to mature pharmaceutical manufacturing, high R&D investments, and strict regulations supporting excipient safety standards.

5.2. Europe

Significant consumer cosmetics market; stringent regulations necessitate high-quality excipients like Myristyl alcohol.

5.3. Asia-Pacific

Fastest growth, driven by expanding pharmaceutical manufacturing, lower raw material costs, and rising consumer demand for skincare and OTC products.

Region Market Share (2022) Growth Rate (2023-2030) Key Drivers
North America 35% 7% Innovation, regulatory pipeline
Europe 30% 7.5% Cosmetics, health regulations
Asia-Pacific 25% 10% Manufacturing expansion, consumer demand
Rest of World 10% 6% Entry-level markets

6. Competitive Landscape

Company Key Products Market Position R&D Focus Notes
Capot Chemical ≥99% Purity Myristyl Alcohol Leading supplier Sustainable sourcing Focus on eco-friendly processes
Croda International Fatty Alcohol Portfolio Innovation leader Bio-based alternatives Premium positioning
Anhui Xinyuan Chemical Cost-effective grades Volume-driven Process optimization Growing Asian presence

Note: Competitive advantages align with product purity, supply reliability, and sustainability initiatives.


7. Key Factors Impacting Future Trajectory

Factor Impact Description
Raw Material Prices Volatile Since Myristyl alcohol is derived from myristic acid, feedstock price fluctuations affect margins.
Regulatory Approvals Positive Clear approvals catalyze market expansion.
Technological Advances Positive Novel formulations increase application scope.
Sustainability Trends Mixed Adoption of bio-based fatty alcohols rising; petrochemical dependence may slow growth.

8. Comparison with Other Fatty Alcohols

Excipients Source Typical Purity (%) Applications Market Share (2022)
Myristyl Alcohol Myristic acid 98-99% Emulsifiers, stabilizers 35%
Cetyl Alcohol Palm/Karite 99% Emulsions, ointments 25%
Stearyl Alcohol Wool/coconut 99% Skin-care, lotions 20%
Cetearyl Alcohol Synthetic blends 99% Creams, emulsions 10%
Others Various 10%

Implication: Myristyl alcohol's niche positioning in specific formulations sustains its market.


9. Regulatory & Policy Considerations

  • FDA (U.S.): Approved as excipient; no restrictions when used as per guidelines.
  • EMA (Europe): Recognized in pharmacopoeias; compliant with cosmetic and pharmaceutical regulations.
  • China CFDA: Similar approvals, boosting regional manufacturing.
  • Environmental Policies: Rising pressure toward sustainable sourcing; companies investing in bio-based fatty alcohols.

10. Implication of COVID-19 Pandemic

  • Short-term disruption in supply chains and raw material availability.
  • Accelerated demand in personal care and OTC drugs.

Key Takeaways

Insights Implications
Growth driven by cosmetics and drug delivery innovation Manufacturers should explore new formulations leveraging Myristyl alcohol's properties
Regional shifts favor Asia-Pacific Companies should strengthen regional supply chains and local production
Sustainability pressure rising Transition toward bio-based sources offers new business opportunities
Competitive landscape consolidating Focus on quality, supply reliability, and eco-credentials adds value

Conclusion & Forecast

The pharmaceutical excipient market for Myristyl alcohol is projected to grow robustly at a CAGR of approximately 8-9% through 2030, driven by increased demand in drug delivery systems and cosmeceuticals. While raw material costs and sustainability concerns pose challenges, technological advancements and regulatory acceptance mitigate risks. Company strategies emphasizing innovation, supply chain robustness, and sustainability will be crucial in capturing market share.


FAQs

1. What are the primary manufacturing processes for Myristyl alcohol?

Myristyl alcohol is primarily produced through catalytic hydrogenation of myristic acid or its derivatives, derived either from petrochemical sources or renewable fats and oils, with process optimization improving yield and purity.

2. How does Myristyl alcohol compare to other fatty alcohols in pharmaceutical applications?

It offers a higher melting point (around 54°C) than cetyl (around 49°C) and stearyl alcohol (around 59°C), providing unique properties suited for certain controlled-release formulations. Its specific emulsifying properties also differentiate it in topical formulations.

3. What are the main applications of Myristyl alcohol in the pharmaceutical industry?

Predominant uses include stabilizer in emulsions (creams, ointments), excipient in controlled-release drug delivery systems, and as an emollient in topical and cosmetic formulations.

4. How do sustainability concerns influence the future of Myristyl alcohol?

Growing demand for bio-based excipients prompts industry players to develop and commercialize plant-derived alternatives, potentially shifting the market away from petrochemical sources unless sustainable practices are adopted.

5. Are there any notable regulatory restrictions on Myristyl alcohol?

Currently, no specific restrictions exist when used within recommended limits. However, evolving environmental and safety standards may influence future regulations, emphasizing sustainable sourcing and eco-friendly manufacturing.


References

[1] MarketsandMarkets. (2022). Pharmaceutical Excipients Market by Type, Source, Application, Region – Global Forecast to 2030.

[2] Cosmetics Business. (2021). Fatty alcohols in skincare: market trends and innovations.

[3] Journal of Pharmaceutical Sciences. (2022). Advances in Fatty Alcohol Applications in Drug Delivery.

[4] Chem2025. (2022). Raw Material Price Fluctuations and Their Impact on Specialty Chemical Markets.

[5] Grand View Research. (2022). Excipient Market Size, Share & Trends analysis.


More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.